Oncodigm BioPharma (NASDAQ: ONTY) (TSX: ONY)

Liposomal formulation of recombinant IL-2 for use as chemotherapy or cancer vaccine adjuvant

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Oncodigm BioPharma (NASDAQ: ONTY) (TSX: ONY) plus 5056 other startups.

Start Free 7 Day Trial Now

Learn More About Oncodigm BioPharma (NASDAQ: ONTY) (TSX: ONY)

Technology/product details

Competing Startups

More

Our Clients